Anonymous
Guest
Anonymous
Guest
You're all fired for posting on cafepharma, ya scurvy dogs.
"AMRN's BO price will be zero. No one will pay anything for AMRN.
Lovaza is superior and WAY cheaper to produce.
No one needs to pay AMRN anything to sell pure EPA, anyone can sell it without prescription tomorrow and any big pharma can run a couple of trials and go around or crush AMRN's laughable patents in the courts.
Big Pharma does not pay a dime more than they have to for anything.
But since pure EPA can't possibly be profitable with generic Lovaza on the market, no one will bother.
They will just sit back and laugh at Amarin going bankrupt trying to sell this economically worthless product."
-From AMRN's Yahoo message board..
"AMRN's BO price will be zero. No one will pay anything for AMRN.
Lovaza is superior and WAY cheaper to produce.
No one needs to pay AMRN anything to sell pure EPA, anyone can sell it without prescription tomorrow and any big pharma can run a couple of trials and go around or crush AMRN's laughable patents in the courts.
Big Pharma does not pay a dime more than they have to for anything.
But since pure EPA can't possibly be profitable with generic Lovaza on the market, no one will bother.
They will just sit back and laugh at Amarin going bankrupt trying to sell this economically worthless product."
-From AMRN's Yahoo message board..
"AMRN's BO price will be zero. No one will pay anything for AMRN.
Lovaza is superior and WAY cheaper to produce.
No one needs to pay AMRN anything to sell pure EPA, anyone can sell it without prescription tomorrow and any big pharma can run a couple of trials and go around or crush AMRN's laughable patents in the courts.
Big Pharma does not pay a dime more than they have to for anything.
But since pure EPA can't possibly be profitable with generic Lovaza on the market, no one will bother.
They will just sit back and laugh at Amarin going bankrupt trying to sell this economically worthless product."
-From AMRN's Yahoo message board..
Nice....hack. It seems to me that Amarin wouldn't be spending the money to do an outcomes trial if it was as the writer above says. My Cardiologist is impressed with the data he saw. Who knows. Where in the hell is Eliquis...Buehler, Buehler? I wanna sell to the Cards again!
AMRN has already filed an NDA foe Vascepa /Lipitor combo. Feels like a Pfizer partnership is just inevitable. I don't think AZ would promote anything w/ Lipitor in it.
AMRN has already filed an NDA foe Vascepa /Lipitor combo. Feels like a Pfizer partnership is just inevitable. I don't think AZ would promote anything w/ Lipitor in it.
It's pending approval, stupid. Try reading the company press releases instead of trying to pimp your worthless stock on a drug co. message board. If we wanted to sell fish oil we wouldn't buy a company in order to do so - we'd just make our own for chrissakes.